Prime Highlights: UltraGreen has received regulatory approval for Verdye in the Philippines and IC-Flow Imaging System V2 in Malaysia, marking a major step in its Southeast Asia expansion. The approvals…
Prime Highlights: Vietnam’s pharmaceutical industry is growing steadily, with exports reaching $312 million in 2025, placing the country fourth in Southeast Asia. Regulatory reforms and digital transformation are boosting efficiency,…
Prime Highlights DKSH Technology has signed an agreement to acquire Vietnam-based Biomedic, expanding its life sciences and healthcare footprint in the country. The acquisition supports DKSH’s regional growth strategy and…
Prime Highlights Experts emphasize collaboration over competition as key to Singapore’s biotech strategy and sustainable growth. Long-term planning, risk management, and shared investment across projects are crucial for success in…
Prime Highlights Indonesia’s Ministry of Health is expanding access to advanced diagnostic imaging nationwide under the SIHREN programme to improve healthcare for over 280 million people. GE HealthCare will supply…
Prime Highlights Zuellig Pharma has expanded its partnership with Danish drugmaker Lundbeck to improve access to brain health medicines across Asia. The collaboration highlights Zuellig Pharma’s continued focus on strengthening…
Prime Highlights China will begin fully reimbursing all childbirth-related medical expenses nationwide from next year to reduce financial pressure on families. The policy is part of broader efforts to address…
Prime Highlight China’s growing BCI research is helping patients with paralysis, including those with ALS, regain basic movements by decoding brain activity. Experts describe BCI as a bridge that translates…
Prime Highlights: Yikon Genomics launches its first lab in Malaysia to improve reproductive and preventive healthcare across the Asia-Pacific region. The lab will work with local hospitals, fertility centers, and…
Prime Highlights: China unveiled its first catalog of innovative drugs, featuring 19 treatments from global and domestic companies, targeting cancer, Alzheimer’s, and rare genetic disorders. The catalog allows high-priced medicines,…
